Provexis plc Cash Flow Conversion Efficiency

Latest as of September 2025: -0.307x

Provexis plc cash flow conversion efficiency. Based on the latest financial reports, Provexis plc (PXS) has a cash flow conversion efficiency ratio of -0.307x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-187.53K ≈ $-22.82 USD) by net assets (GBX610.89K ≈ $74.33 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Provexis plc (2004–2025)

Cash flow conversion efficiency of Provexis plc from 2004 to 2025. This chart illustrates how Provexis plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Provexis plc for real-time trading data and today's change.

Provexis plc Cash Flow Conversion Ratio Explained

Provexis plc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Provexis plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Provexis plc ranked by their cash flow conversion efficiency. Also see PXS market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Benson Hill, Inc. Common Stock NYSE:BHIL	-0.533x
Atlas Corp NASDAQ:ATCOL	0.083x
Cobalt Power Group Inc V:PGP	0.016x
Horizon Technology Finance Corporation NYSE:HTFB	0.027x
Kaival Brands Innovations Group Inc NASDAQ:KAVL	-1.514x
Atlantis Resources Ltd LSE:SAE	-0.022x
Dianomi PLC LSE:DNM	-0.364x
INLIF LIMITED Ordinary Shares NASDAQ:INLF	0.065x

Annual Cash Flow Conversion Efficiency for Provexis plc (2004–2025)

The table below shows the annual cash flow conversion efficiency of Provexis plc from 2004 to 2025. Review how much free cash does Provexis plc generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	GBX763.82K ≈ $92.93	GBX-340.83K ≈ $-41.47	-0.446x	+55.59%
2024-03-31	GBX190.59K ≈ $23.19	GBX-191.50K ≈ $-23.30	-1.005x	-27.11%
2023-03-31	GBX657.65K ≈ $80.02	GBX-519.85K ≈ $-63.25	-0.790x	-258.73%
2022-03-31	GBX969.08K ≈ $117.91	GBX-213.54K ≈ $-25.98	-0.220x	+3.97%
2021-03-31	GBX1.14 Million ≈ $138.97	GBX-262.07K ≈ $-31.89	-0.229x	+78.15%
2020-03-31	GBX318.68K ≈ $38.77	GBX-334.64K ≈ $-40.72	-1.050x	+7.33%
2019-03-31	GBX338.89K ≈ $41.23	GBX-384.01K ≈ $-46.72	-1.133x	-2.77%
2018-03-31	GBX329.26K ≈ $40.06	GBX-363.05K ≈ $-44.17	-1.103x	+93.62%
2017-03-31	GBX24.89K ≈ $3.03	GBX-430.30K ≈ $-52.36	-17.291x	-574.63%
2016-03-31	GBX142.84K ≈ $17.38	GBX-366.10K ≈ $-44.54	-2.563x	-55.70%
2015-03-31	GBX245.90K ≈ $29.92	GBX-404.78K ≈ $-49.25	-1.646x	-53.62%
2014-03-31	GBX535.08K ≈ $65.10	GBX-573.34K ≈ $-69.76	-1.072x	-491.02%
2013-03-31	GBX7.91 Million ≈ $961.92	GBX-1.43 Million ≈ $-174.40	-0.181x	+5.42%
2012-03-31	GBX11.30 Million ≈ $1.37K	GBX-2.17 Million ≈ $-263.54	-0.192x	-7.20%
2011-03-31	GBX11.48 Million ≈ $1.40K	GBX-2.05 Million ≈ $-249.79	-0.179x	-31.87%
2010-03-31	GBX11.06 Million ≈ $1.35K	GBX-1.50 Million ≈ $-182.51	-0.136x	+44.43%
2009-03-31	GBX5.53 Million ≈ $673.08	GBX-1.35 Million ≈ $-164.26	-0.244x	-24.48%
2008-03-31	GBX7.58 Million ≈ $922.88	GBX-1.49 Million ≈ $-180.92	-0.196x	+40.54%
2007-03-31	GBX6.61 Million ≈ $804.12	GBX-2.18 Million ≈ $-265.12	-0.330x	-6.14%
2006-03-31	GBX8.85 Million ≈ $1.08K	GBX-2.75 Million ≈ $-334.47	-0.311x	+87.48%
2005-03-31	GBX510.00K ≈ $62.05	GBX-1.26 Million ≈ $-153.91	-2.480x	+64.89%
2004-03-31	GBX108.00K ≈ $13.14	GBX-763.00K ≈ $-92.84	-7.065x	--

About Provexis plc

LSE:PXS UK Drug Manufacturers - Specialty & Generic

Market Cap

$244.04K

GBX2.01 Billion GBX

Market Cap Rank

#31308 Global

#1002 in UK

Share Price

GBX0.86

Change (1 day)

+0.00%

52-Week Range

GBX0.56 - GBX1.51

All Time High

GBX1.51